Skip to Content
Merck

Bypassing pan-enterovirus host factor PLA2G16.

Nature communications (2019-07-20)
Jim Baggen, Yue Liu, Heyrhyoung Lyoo, Arno L W van Vliet, Maryam Wahedi, Jost W de Bruin, Richard W Roberts, Pieter Overduin, Adam Meijer, Michael G Rossmann, Hendrik Jan Thibaut, Frank J M van Kuppeveld
ABSTRACT

Enteroviruses are a major cause of human disease. Adipose-specific phospholipase A2 (PLA2G16) was recently identified as a pan-enterovirus host factor and potential drug target. In this study, we identify a possible mechanism of PLA2G16 evasion by employing a dual glycan receptor-binding enterovirus D68 (EV-D68) strain. We previously showed that this strain does not strictly require the canonical EV-D68 receptor sialic acid. Here, we employ a haploid screen to identify sulfated glycosaminoglycans (sGAGs) as its second glycan receptor. Remarkably, engagement of sGAGs enables this virus to bypass PLA2G16. Using cryo-EM analysis, we reveal that, in contrast to sialic acid, sGAGs stimulate genome release from virions via structural changes that enlarge the putative openings for genome egress. Together, we describe an enterovirus that can bypass PLA2G16 and identify additional virion destabilization as a potential mechanism to circumvent PLA2G16.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Fondaparinux sodium, ≥95% (HPLC)
Sigma-Aldrich
Heparin sodium salt from porcine intestinal mucosa, ≥180 USP units/mg
Sigma-Aldrich
Chlorpromazine hydrochloride, ≥98% (TLC)